Byrd told hardly anyone — not in junior high, not through four years of high school, not when he first arrived at SDSU in ...

The recall affects Dexcom G6, G7, ONE, and ONE+ continuous glucose monitor receivers but not the smartphone apps or insulin ...

DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Click here to read ...

FDA recalls Dexcom glucose monitors (G6, G7, ONE models) due to alert issues posing severe health risks. Read more here.

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of ...

Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The affected devices are models ...

The FDA approved insulin aspart-xjhz (Kirsty) for adults and kids with diabetes mellitus, the first rapid-acting interchangeable biosimilar to reference Novolog. People who bought weight-loss ...

Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components.

The U.S. Food and Drug Administration has announced a recall of specific Dexcom (NASDAQ:DXCM) glucose monitoring devices, including the G6, G7, ONE, and ONE+ models. The recall is due to a potential ...